{"id":"tp-46816","type":"article-newspaper","title":"Pfizer Faces 16% EPS Decline Estimate as Q3 Report Nears","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/46816","datePublished":"2026-11-02T19:23:52.000Z","dateModified":"2026-11-02T19:23:52.000Z","language":"en","abstract":"Analysts project revenue of $15.88 billion, down 4.6%, as investors look for updates on cost cuts, drug exclusivity and a Metsera-linked obesity candidate.","section":"Business","references":[{"title":"an earlier list of upcoming third-quarter reports","url":"https://www.tokenpost.com/news/business/45535"}]}